Michael Akers earned a bachelor’s degree in biology from Wabash College in Crawfordsville, Ind. and a PhD in Pharmaceutics from the University of Iowa College of Pharmacy, where his major professor was John L. Lach.
In his 40-year career, Akers was employed in various scientific and administrative positions at Searle Laboratories in Skokie, Ill.; Alcon Laboratories in Fort Worth, Texas; the University of Tennessee College of Pharmacy in Memphis, Tenn.; Eli Lilly and Company in Indianapolis, Ind.; and Baxter BioPharma Solutions in Bloomington, Ind. He was involved with the development, manufacturing, and regulatory filing of many new drug applications (NDA) and NDA supplements.
He was active in elected leadership positions in the American Association of Pharmaceutical Scientists (AAPS) and Parenteral Drug Association, and is a Fellow of AAPS. He was editor-in-chief of the peer-reviewed scientific journal, Pharmaceutical Development and Technology, for 16 years. He has published over 100 research articles, teaching articles, review articles, and book chapters, and authored or edited six books.